Past events

November 26, 2021 at 13:00 (CET)

Webinar: Presentation of the Q3 report by CEO Fernando Andreu, CFO Kenneth G. Johansen and CSO Ole Thastrup

Watch Webinar

November 25, 2021

Q3 2021 Interim Report released

View previous reports

November 18, 2021

Presentation by Fernando Andreu (CEO) and Ole Thastrup (CSO) at the Investor-week by the Dansk Shareholder’s Association

Read more

November 15, 2021

Presentation by Ole Thastrup (CSO 2cureX) at the TechConnect Europe Innovation Conference & Expo (Malmø, Sweden)

Read more

October 21, 2021

Presentation by Henrik Harling (CMO 2cureX) at the 17. National Congress of Digestive Cancers (Viseu, Portugal)

Read more

October 5, 2021 at 15:00 (CET)

Precision Oncology Webinar: Beyond Biomarkers. Clinical Peers (Dr. John Lindsay Marshall, from Georgetown University Hospital, US and Dr Jesús García-Foncillas, from University Hospital Fundación Jimenez Diaz, Madrid, Spain and Dr. Lars Henrik Jensen, University Hospital Vejle, DK) present the role of the functional test IndiTreat® in personalized oncology to oncologists and 2cureX’s Distributors (promoted on Oncology Convention website, UK. Open participation.

Read more and Register

September 29, 2021

Mangold Investor Lunch

Read more

September 28, 2021

Redeye Medtech & Diagnostics Investor meeting

Read more

September 23, 2021

CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark

Read more and Register

September 15, 2021 at 15:00 (CET)

Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.

Read more

September 12, 2021 at 13:00 (CET)

Strategy update Webinar. CSO Fernando Andreu, CSO Ole Thastrup, VP Business Development Pia van der Zee and VP Sales Jesper F. Kristiansen provide a strategy update to investors, analysts, and media.

Read more

August 27, 2021 at 14:00 (CET)

Webinar: Presentation of the Q2 report by CEO Fernando Andreu, CFO Kenneth G. Johansen and CSO Ole Thastrup

Watch Webinar

August 26, 2021

Q2 2021 Interim Report released

View previous reports

June 2, 2021

Redeye Growth Day 2021, Stockholm

Read more

May 27, 2021

Annual General Meeting

View previous reports

May 27, 2021

Interim Report Q1 2021

View previous reports

May 26, 2021

Life Science Investor Conference, Copenhagen

Read more

May 5, 2021

Redeye Investor theme: Medtech & Diagnostics, Stockholm

Read more

March 16, 2021

CEO meets young investors, link to event will follow

Read more

March 2, 2021

Nordnet Online Event

Read more

March 4, 2021

RedEye Investor Forum Online

Read more

February 25, 2021

Year-End Report 2020

View previous reports

February 10, 2021

VATOR SWISS NORDIC BIO 2021 – The Annual Nordic Healthcare Investor Summit in Zürich

Read more

January 21, 2021

Fight Cancer 2021, Redeye Event, Stockholm

Click here for more information

December 15-16, 2020

Virtual European Innovation Council Meeting in Berlin,

Read more

October 19-21, 2020

TechConnect EUROPE, Malmö, Sweden

Read more

September 18, 2020

European Society of Medical Oncology, ESMO Congress 2020, Virtual

Read more

September 3, 2020

REDEYE Investor Forum Online

Read more

July 1, 2020

World Congress on Gastrointestinal Cancer, ESMO GI, Barcelona, Spain - VIRTUAL

Read more

May 29, 2020

2cureX live presentation of the Annual Report 2019

View here

May 26, 2020

American Society of Clinical Oncology, ASCO, Chicago, USA

Read more

March 17, 2020

Oncology Convention 2020, Birmingham, UK

Read more

March 11, 2020

Sedermeradagen Copenhagen 2020

Read more

March 10, 2020

Fight Cancer Seminar (RedEye), Stockholm, Sweden

View here

February 19-22, 2020

German Cancer Congress, 34 Deutscher Krebs Kongress 2020, Berlin, Germany

Read more

December 11-14, 2019

ESMO Immuno-Oncology Congress 2019

Read more

October 22, 2019

Kiel Oncology Network, Kiel, Germany

Read more

October 7-8, 2019

Nyborg (DK), Individual prevention of rectal cancer

Read more

October 4, 2019

Gothenburg, Sedermeradagen, Sedermera Fondkommission

View here

October 1, 2019

Sedermera Investor Lunch, Copenhagen, Denmark

Read more

September 27 – October 1, 2019

Barcelona, ESMO (Eur. Soc. Medical Oncology) congress 2019: Translating science into better cancer patient care

Read more

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.